S C Schachter

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi Quality of life for patients with epilepsy is determined by more than seizure control: the role of psychosocial factors
    Steven C Schachter
    Harvard Medical School, Boston, MA 02215, USA
    Expert Rev Neurother 6:111-8. 2006
  2. ncbi Seizure disorders
    Steven C Schachter
    Department of Neurology, Harvard Medical School, MA, USA
    Med Clin North Am 93:343-51, viii. 2009
  3. ncbi Vagus nerve stimulation: mood and cognitive effects
    Steven C Schachter
    Department of Neurology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA
    Epilepsy Behav 5:S56-9. 2004
  4. ncbi Seizure disorders
    Steven C Schachter
    Department of Neurology, Harvard Medical School, Boston, MA, USA
    Prim Care 31:85-94. 2004
  5. ncbi Advances in the application of technology to epilepsy: the CIMIT/NIO Epilepsy Innovation Summit
    Steven C Schachter
    Center for Integration of Medicine and Innovative Technology, Boston, MA, USA
    Epilepsy Behav 16:3-46. 2009
  6. ncbi Oxcarbazepine: double-blind, randomized, placebo-control, monotherapy trial for partial seizures
    S C Schachter
    Department of Neurology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA
    Neurology 52:732-7. 1999
  7. ncbi The visions of artists with epilepsy: implications for neuroscientists
    Steven C Schachter
    Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
    Epilepsy Behav 14:12-4. 2009
  8. ncbi What needs to change: goals for clinical and social management and research in the next 60 years
    Steven C Schachter
    Departments of Neurology, Beth Israel Deaconess Medical Centre and Harvard Medical School, 330 Brookline Avenue, K 478, Boston, MA 02215, USA
    Seizure 19:686-9. 2010
  9. ncbi Complementary and alternative medical therapies
    Steven C Schachter
    Osher Research Center, Harvard Medical School, Boston, Massachusetts 02215, USA
    Curr Opin Neurol 21:184-9. 2008
  10. ncbi Flurothyl-induced seizures in rats activate Fos in brainstem catecholaminergic neurons
    D C Silveira
    Department of Neurology, Beth Israel Deaconess Medical Center, Kirstein 478 and Harvard Medical School, Boston, MA 02115, USA
    Epilepsy Res 39:1-12. 2000

Detail Information

Publications41

  1. ncbi Quality of life for patients with epilepsy is determined by more than seizure control: the role of psychosocial factors
    Steven C Schachter
    Harvard Medical School, Boston, MA 02215, USA
    Expert Rev Neurother 6:111-8. 2006
    ..Irrespective of their level of seizure control from antiepileptic drugs, patients may also benefit from targeted psychosocial interventions that reduce the negative impact of these factors on their quality of life...
  2. ncbi Seizure disorders
    Steven C Schachter
    Department of Neurology, Harvard Medical School, MA, USA
    Med Clin North Am 93:343-51, viii. 2009
    ..Special considerations are warranted for women of childbearing potential and elderly patients...
  3. ncbi Vagus nerve stimulation: mood and cognitive effects
    Steven C Schachter
    Department of Neurology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA
    Epilepsy Behav 5:S56-9. 2004
    ..This review evaluates the published evidence for VNS-associated changes in mood and cognition in patients with neuropsychiatric disorders...
  4. ncbi Seizure disorders
    Steven C Schachter
    Department of Neurology, Harvard Medical School, Boston, MA, USA
    Prim Care 31:85-94. 2004
  5. ncbi Advances in the application of technology to epilepsy: the CIMIT/NIO Epilepsy Innovation Summit
    Steven C Schachter
    Center for Integration of Medicine and Innovative Technology, Boston, MA, USA
    Epilepsy Behav 16:3-46. 2009
    ..This article summarizes the discussions and demonstrates that cross-disciplinary interactions can catalyze collaborations between physicians and engineers to address and solve many of the pressing unmet needs in epilepsy...
  6. ncbi Oxcarbazepine: double-blind, randomized, placebo-control, monotherapy trial for partial seizures
    S C Schachter
    Department of Neurology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA
    Neurology 52:732-7. 1999
    ..To evaluate the efficacy and safety of oxcarbazepine in a placebo-control trial...
  7. ncbi The visions of artists with epilepsy: implications for neuroscientists
    Steven C Schachter
    Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
    Epilepsy Behav 14:12-4. 2009
    ....
  8. ncbi What needs to change: goals for clinical and social management and research in the next 60 years
    Steven C Schachter
    Departments of Neurology, Beth Israel Deaconess Medical Centre and Harvard Medical School, 330 Brookline Avenue, K 478, Boston, MA 02215, USA
    Seizure 19:686-9. 2010
    ....
  9. ncbi Complementary and alternative medical therapies
    Steven C Schachter
    Osher Research Center, Harvard Medical School, Boston, Massachusetts 02215, USA
    Curr Opin Neurol 21:184-9. 2008
    ..This review highlights the findings of recently published studies of complementary and alternative medical therapies and epilepsy, and provides an update of the US Food and Drug Administration's role in regulating herbal products...
  10. ncbi Flurothyl-induced seizures in rats activate Fos in brainstem catecholaminergic neurons
    D C Silveira
    Department of Neurology, Beth Israel Deaconess Medical Center, Kirstein 478 and Harvard Medical School, Boston, MA 02115, USA
    Epilepsy Res 39:1-12. 2000
    ..Further studies are necessary to determine whether activation of brainstem catecholaminergic neurons contribute to the autonomic manifestations that frequently accompany epileptic seizures...
  11. ncbi Comparison of coronal sphenoidal versus standard anteroposterior temporal montage in the EEG recording of temporal lobe seizures
    J R Ives
    Department of Neurology, Beth Israel Hospital, Harvard Medical School, Boston, MA 02215, USA
    Electroencephalogr Clin Neurophysiol 98:417-21. 1996
    ..Indwelling, flexible sphenoidal electrodes assist in ambulatory recording of temporal lobe seizures, both in demonstrating the presence of seizures and in determining the localization and time of seizure onset...
  12. ncbi Botanicals and herbs: a traditional approach to treating epilepsy
    Steven C Schachter
    Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
    Neurotherapeutics 6:415-20. 2009
    ..S. Food and Drug Administration in regulating herbal products, and presents the author's approach to the scientific assessment of herbal therapies as potential therapies for patients with epilepsy...
  13. ncbi Improving quality of life beyond seizure control
    Steven C Schachter
    Comprehensive Epilepsy Program, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
    Epileptic Disord 7:S34-8. 2005
    ....
  14. ncbi Transcranial magnetic stimulation treatment for epilepsy: can it also improve depression and vice versa?
    Felipe Fregni
    Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA
    Epilepsy Behav 7:182-9. 2005
    ..This article reviews these data and explores further the question of whether depression and epilepsy can be simultaneously treated with TMS for optimal therapeutic impact...
  15. ncbi Complementary and alternative medicine use among US adults with common neurological conditions
    Rebecca Erwin Wells
    Division for Research and Education in Complementary and Integrative Medical Therapies, Osher Research Center, Harvard Medical School, Landmark Center, Suite 22A West, Boston, MA 02215, USA
    J Neurol 257:1822-31. 2010
    ..CAM is used more frequently among adults with common neurological conditions than those without. More research on the efficacy of CAM use for common neurological conditions is warranted...
  16. ncbi Vagus nerve stimulation: where are we?
    Steven C Schachter
    Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
    Curr Opin Neurol 15:201-6. 2002
    ..This review evaluates the role of vagus nerve stimulation in light of recently published research of its mechanism(s) of action, long-term efficacy, safety and tolerability, and application to other disorders besides epilepsy...
  17. ncbi Repetitive transcranial magnetic stimulation in the treatment of epilepsia partialis continua
    Alexander Rotenberg
    Department of Neurology, Children s Hospital, Harvard Medical School, Boston, MA 02115, USA
    Epilepsy Behav 14:253-7. 2009
    ..Here, we describe our recent experience with rTMS in the treatment of EPC, as an early step toward evaluating the safety and efficacy of rTMS in the treatment of intractable ongoing focal seizures...
  18. ncbi Epilepsy: major advances in treatment
    Steven C Schachter
    Harvard Medical School, Boston, Massachusetts, USA
    Lancet Neurol 3:11. 2004
  19. ncbi A patient with a new-onset seizure after a stroke
    Steven C Schachter
    Harvard Medical School, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA
    Epilepsy Behav 4:S23-6; discussion S27-8. 2003
  20. ncbi Current evidence indicates that antiepileptic drugs are anti-ictal, not antiepileptic
    Steven C Schachter
    Department of Neurology, Harvard Medical School, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA
    Epilepsy Res 50:67-70. 2002
    ..This paper suggests methods by which drugs could be tested for antiepileptic properties and reviews whether current antiepilectic drugs (AEDs) are antiepileptic in addition to being effective for seizure suppression...
  21. ncbi Drug-mediated antiepileptogenesis in humans
    Steven C Schachter
    Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Avenue, K 478, Boston, MA 02215, USA
    Neurology 59:S34-5. 2002
    ..e., a cure. Whether any anticonvulsant drugs in current use have antiepileptogenic properties is the subject of this overview...
  22. ncbi Management of epilepsy: pharmacologic therapy and quality-of-life issues
    S C Schachter
    Harvard Medical School, Boston, MA, USA
    Postgrad Med 101:133-8, 141-4, 150-3. 1997
    ....
  23. ncbi Technical implementation and clinical findings/results of monitoring oxygen saturation in patients referred for long-term EEG monitoring
    J R Ives
    Department of Neurology, Beth Israel Hospital, Boston, MA 02215, USA
    Electroencephalogr Clin Neurophysiol 99:432-9. 1996
    ..From a research aspect, the details of the morphology and timing of the oxygen desaturations and EEG show several interesting relationships with respect to the dynamics of seizure semiology and respiratory physiology...
  24. ncbi High strength stimulation of the vagus nerve in awake humans: a lack of cardiorespiratory effects
    A P Binks
    Physiology Program, Harvard School of Public Health, 665 Huntington Avenue, Boston, MA 02115, USA
    Respir Physiol 127:125-33. 2001
    ....
  25. ncbi Therapeutic effects of vagus nerve stimulation in epilepsy and implications for sudden unexpected death in epilepsy
    Steven C Schachter
    Harvard Medical School, Dept. of Neurology, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Room K-478, Boston, MA 02215, USA
    Clin Auton Res 16:29-32. 2006
    ..Studies to date of VNS and SUDEP are limited and do not conclusively show an association between VNS and SUDEP rates independent of other epilepsy-specific variables...
  26. ncbi Remacemide: current status and clinical applications
    S C Schachter
    Departments of Neurology, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, K 478, Boston, MA 02215, USA
    Expert Opin Investig Drugs 9:871-83. 2000
    ..Adverse effects are related to the gastrointestinal and central nervous systems. RMC is a promising drug with numerous potential applications for both acute or chronic conditions associated with glutamate-mediated neurotoxicity...
  27. ncbi Pharmacology and clinical experience with tiagabine
    S C Schachter
    Office of Clinical Trials and Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    Expert Opin Pharmacother 2:179-87. 2001
    ..Open studies confirm that patients with medically refractory partial epilepsy can be successfully converted to TGB monotherapy and that TGB may be effective for other seizure types, such as infantile spasms...
  28. ncbi Vagus nerve stimulation therapy summary: five years after FDA approval
    Steven C Schachter
    Department of Neurology, Harvard Medical School and Beth Israel Deaconess Medical Center, 330 Brookline Avenue, KS 457, Boston, MA 02215, USA
    Neurology 59:S15-20. 2002
    ..Additional studies are suggested to further explore the capabilities of VNS therapy...
  29. ncbi Mutations in the X-linked filamin 1 gene cause periventricular nodular heterotopia in males as well as in females
    V L Sheen
    Department of Neurology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02115, USA
    Hum Mol Genet 10:1775-83. 2001
    ..These results demonstrate the sensitivity and specificity of DNA testing for FLN1 mutations and have important functional implications for models of FLN1 protein function in neuronal migration...
  30. ncbi Increased susceptibility to generalized seizures after immunolesions of the basal forebrain cholinergic neurons in rats
    D C Silveira
    Department of Neurology, Children s Hospital and Harvard Medical School, 300 Longwood Avenue, Enders 320, Boston, MA 02115, USA
    Brain Res 878:223-7. 2000
    ..Lesioned rats had significantly shorter latencies to onset of generalized tonic-clonic seizures than controls. Our findings suggest that basal forebrain cholinergic neurons may participate in the modulation of generalized seizures...
  31. ncbi Huperzine A regulates amyloid precursor protein processing via protein kinase C and mitogen-activated protein kinase pathways in neuroblastoma SK-N-SH cells over-expressing wild type human amyloid precursor protein 695
    Y Peng
    Center for Neurologic Diseases, Harvard Medical School and Brigham and Women s Hospital, Harvard New Research Building, Room 636F, 77 Avenue Louis Pasteur, Boston, MA 02115, USA
    Neuroscience 150:386-95. 2007
    ....
  32. ncbi Currently available antiepileptic drugs
    Steven C Schachter
    Harvard Medical School, Boston, Massachusetts 02215, USA
    Neurotherapeutics 4:4-11. 2007
    ..Consequently, there remains a significant need for further development of new therapies...
  33. ncbi Emerging credentialing practices, malpractice liability policies, and guidelines governing complementary and alternative medical practices and dietary supplement recommendations: a descriptive study of 19 integrative health care centers in the United Stat
    Michael H Cohen
    Harvard Medical School Osher Institute and the Division for Research and Education in Complementary and Integrative Medical Therapies, Harvard Medical School, Boston, MA 02215, USA
    Arch Intern Med 165:289-95. 2005
    ..Consensus policies need to be developed...
  34. ncbi The evolving place of vagus nerve stimulation therapy
    Steven C Schachter
    Department of Neurology, Harvard Medical School and Beth Israel Deaconess Medical Center, 330 Brookline Avenue, KS 457, Boston, MA 02215, USA
    Neurology 59:S1-2. 2002
    ..This supplement updates developments with VNS therapy since its approval and suggests future directions for this still-evolving treatment...
  35. ncbi Endocrine aspects of epilepsy
    Steven C Schachter
    Department of Neurology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
    Adv Neurol 90:175-84. 2002
  36. ncbi Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society
    Jacqueline A French
    Neurological Institute, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Epilepsia 45:410-23. 2004
    ....
  37. ncbi Lack of herbal supplement characterization in published randomized controlled trials
    Peter M Wolsko
    Kaiser Permanente Medical Group, Denver, CO 80020, USA
    Am J Med 118:1087-93. 2005
    ..We assessed the extent to which recently published randomized controlled trials of herbal supplements characterized and verified the content of the supplement under study...
  38. ncbi Epilepsy surveillance among adults--19 States, Behavioral Risk Factor Surveillance System, 2005
    Rosemarie Kobau
    Division of Adult and Community Health, National Center for Chronic Disease Prevention and Health Promotion, CDC, 4770 Buford Hwy, N E, MS K 51, Atlanta, GA 30347, USA
    MMWR Surveill Summ 57:1-20. 2008
    ....
  39. ncbi Increasing research capacity at the New England School of Acupuncture through faculty and student research training initiatives
    Peter M Wayne
    New England School of Acupuncture NESA, Watertown, Massachusetts, USA
    Altern Ther Health Med 14:52-8. 2008
    ..We discuss successes and challenges encountered in developing and administering these initiatives and the overall impact they have had on research culture and productivity at NESA...
  40. ncbi Efficacy and tolerability of the new antiepileptic drugs, I: Treatment of new-onset epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society
    Jacqueline A French
    Neurological Institute, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Epilepsia 45:401-9. 2004
    ..S. Food and Drug Administration] in the treatment of children and adults with newly diagnosed partial and generalized epilepsies...
  41. ncbi Impact of patient-specificity on seizure onset detection performance
    Ali Shoeb
    Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, USA
    Conf Proc IEEE Eng Med Biol Soc 2007:4110-4. 2007
    ....